Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Almotriptan for mild pain phase of menstrual migraine
2005-000244-90Phase 4Completed
- Sponsor
- Almirall
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of almotriptan in Catamenial Migraine and migraine (3 arms), sponsored by Almirall. Primary endpoints: Efficacy in mild pain phase and Tolerability. Started Mar 2005; status: completed.
02
Drugs
almotriptan
03
Conditions
Catamenial Migrainemigraine
Beyond the preview
Go deeper on 2005-000244-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000244-90.